We are live on ! Find out more
ALT icon

Altimmune
ALT

96 hedge funds and large institutions have $336M invested in Altimmune in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 20

56% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 16

46% more capital invested

Capital invested by funds: $231M → $336M (+$106M)

31% more call options, than puts

Call options by funds: $10.9M | Put options by funds: $8.33M

9% more funds holding

Funds holding: 88 → 96 (+8)

2.25% more ownership

Funds ownership: 61.81% → 64.06% (+2.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
36
Reduced
20
Closed
16
Calls
$10.9M
Puts
$8.33M
Net Calls
+$2.59M
Net Calls Change
+$4.09M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$47.6M
2
CCM
CAAS Capital Management
New York
+$17.9M
3
BBA
Baker Bros. Advisors
New York
+$14.1M
4
AC
Armistice Capital
New York
+$8.67M
5
Millennium Management
Millennium Management
New York
+$5.75M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$21.2M
2
VA
VR Adviser
New York
-$16.2M
3
Invesco
Invesco
Georgia
-$4.73M
4
CS
Credit Suisse
Switzerland
-$4.52M
5
EP
Eversept Partners
New York
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
VA
1
VR Adviser
New York
$49.5M -$16.2M -1,000,000 -22%
State Street
2
State Street
Massachusetts
$41.6M +$47.6M +2,942,179 New
BBA
3
Baker Bros. Advisors
New York
$39M +$14.1M +874,067 +46%
Capital World Investors
4
Capital World Investors
California
$19.8M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$18.8M +$1.45M +89,984 +7%
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$18.6M +$1.97M +122,120 +10%
Citadel Advisors
7
Citadel Advisors
Florida
$16M +$330K +20,415 +2%
CCM
8
CAAS Capital Management
New York
$15.6M +$17.9M +1,106,529 New
BlackRock
9
BlackRock
New York
$15M +$1.06M +65,511 +7%
CS
10
Credit Suisse
Switzerland
$12.9M -$4.52M -279,280 -23%
Millennium Management
11
Millennium Management
New York
$10.4M +$5.75M +355,554 +94%
AC
12
Armistice Capital
New York
$7.57M +$8.67M +536,000 New
Invesco
13
Invesco
Georgia
$5.83M -$4.73M -292,575 -41%
ACP
14
Acuta Capital Partners
California
$5.75M -$2.77M -171,445 -30%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$4.65M +$72.5K +4,482 +1%
Citigroup
16
Citigroup
New York
$3.67M +$3.92M +242,535 +1,397%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.52M +$822K +50,872 +26%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$3.34M -$1.75M -108,400 -31%
Wells Fargo
19
Wells Fargo
California
$2.89M -$63.2K -3,912 -2%
Rafferty Asset Management
20
Rafferty Asset Management
New York
$2.81M +$3.21M +198,798 New
MIG
21
McGuire Investment Group
Rhode Island
$2.73M +$2.69M +166,646 +619%
IC
22
Ikarian Capital
Texas
$2.57M +$1.72M +106,496 +141%
Principal Financial Group
23
Principal Financial Group
Iowa
$2.47M +$215K +13,326 +8%
Charles Schwab
24
Charles Schwab
California
$1.93M +$242K +14,973 +12%
Goldman Sachs
25
Goldman Sachs
New York
$1.91M +$1.43M +88,448 +189%
1
2 3 4 5

ALT Hedge Fund Activity: Q1 2021 in Review

96 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2021, worth a combined $336M — up 46% from $231M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ALT positions and 16 closed out — a net gain of 9 holders — while 36 added to existing stakes and 20 trimmed.

The largest buyer was State Street, opening a new position worth an estimated $47.6M. The largest seller was UBS Group, cutting an estimated $21.2M.

  • 96 institutional investors held Altimmune (ALT) as of Q1 2021, up from 88 in Q4 2020.
  • Funds reported $336M of Altimmune stock for Q1 2021, up 46% quarter-over-quarter.
  • 25 funds opened new Altimmune positions in Q1 2021 and 16 closed out, a net change of +9 holders.
  • The largest Altimmune buyer in Q1 2021 was State Street, an estimated $47.6M added.
  • The largest Altimmune seller in Q1 2021 was UBS Group, an estimated $21.2M sold.

Based on aggregated 13F filings for Q1 2021.